Outcome of Board Meeting held on 03rd October, 2026

Date: 03rd October, 2026 BSE Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Sub: Outcome of the Board meeting held on Saturday, 03rd October, 2026 Ref: Scrip Code: 524590 | Symbol: HEMORGANIC | ISIN: INE422G01015 With reference to the subject cited and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), this is to inform to the exchange that meeting of the Board of Directors of Hemo Organic Limited was held on Saturday, the 03rd day of October, 2026 at 06:10 P.M. at the registered office of the Company situated at Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad- 382350, Gujarat, the Board has considered and approved the following: 1. Alteration of Main Objects clause of Memorandum of Association the Company and subsequent alteration to the Clause 3 of the Memorandum of Association of the Company by substituting the existing objects with revised Main Objects, subject to necessary approvals of Members in their meeting and any other regulatory Authorities as may be required, inter alia, covering the activities disclosed hereunder as annexure. 2. Increase in the Authorised Share Capital of the Company from Rs. 13,45,00,000/- (Rupees Thirteen Crore Forty-Five Lakh Only) divided into 1,34,50,000 (One Crore Thirty-Four Lakh Fifty Thousand) Equity Shares of Rs. 10/- each to Rs. 125,00,00,000/- (Rupees One Hundred and Twenty-Five Crore Only) divided into 12,50,00,000 (Twelve Crore Fifty Lakh) Equity Shares of Rs. 10/- each and subsequent alteration in Clause 5 of the Memorandum of Association of the Company, subject to the approval of the shareholders of the Company. 3. Appointment of Ms. Pratibha Sharma (M. No. A38211) as Company Secretary and Compliance Officer of the Company w.e.f. 03rd October, 2026. 4. The Board after due discussion, has deferred the proposal for raising funds to a subsequent meeting of the Board. Accordingly, no decision or approval has been taken by the Board in respect of the proposed fund raising at the meeting held today. The Company shall make a further disclosure/intimation to the Stock Exchange regarding the date and time of the next meeting of the Board of Directors, as and when decided, in compliance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details as per the requirement of Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January 2026 is enclosed hereunder as annexure. The meeting of the Board of Directors was commenced at 06:10 P.M. and concluded at 06:30 P.M. For Hemo Organic Limited Ayush Dharmendrabhai Jasani Chairman & Additional Director DIN: 09842741 The details regarding item No. 1 and 2 as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated 30th January 2026 are as follows: Sl. Particulars Brief Alteration 1. Alteration of the Main Objects of the Alteration of the Main Objects- Clause 3 of Company the Memorandum of Association of the Company by replacing the existing clauses with the following sub-clauses, subject to necessary approvals of Members in their meeting and any other regulatory Authorities as may be required: 1. To carry on the business of purchasing, selling, buying, importing, exporting, trading, dealing, stocking, supplying, distributing, marketing, merchandising and otherwise dealing in diamonds, including rough diamonds, polished diamonds, cut and uncut diamonds, natural diamonds, laboratory-grown diamonds, synthetic diamonds and diamond-related products, articles and materials, whether in India or abroad, and to act as dealers, traders, merchants, distributors, agents, brokers, commission agents, representatives or otherwise in connection therewith. 2. To carry on the business of cutting, polishing, processing, grading, assorting, sorting, manufacturing, designing, finishing and otherwise processing diamonds and diamond-related products, and to establish, acquire, operate, manage or otherwise undertake diamond cutting and polishing units, manufacturing facilities, processing centres, laboratories and other facilities required or incidental thereto. 3. To acquire, purchase, take on lease, license or otherwise obtain, hold, own, develop, construct, build, alter, improve, renovate, repair, maintain, manage, operate, sell, transfer, lease, license, let out, mortgage or otherwise deal in and dispose of residential, commercial, industrial and other buildings, apartments, flats, offices, shops, villas, warehouses, structures, agricultural lands and other parcels of land and other immovable properties, either for the Company’s own use, investment or for earning income therefrom, and to undertake real estate development and construction activities. 4. To purchase, acquire, take over, subscribe to, invest in, hold, own, possess, manage, develop or otherwise deal in shares, stocks, securities, ownership interests, businesses, undertakings or assets of any companies, bodies corporate, firms, limited liability partnerships or other entities engaged in or proposing to engage in the aforesaid objects, and to acquire, consolidate, merge, restructure or otherwise participate in such entities or their businesses, as may be necessary or incidental to the attainment of the foregoing objects. 2. Increase in Authorised Share Capital of Increase in Authorised Share Capital of the the Company Company from Rs. 13,45,00,000/- (Rupees Thirteen Crore Forty-Five Lakh Only) divided into 1,34,50,000 (One Crore Thirty- Four Lakh Fifty Thousand) Equity Shares of Rs. 10/- each to Rs. 125,00,00,000/- (Rupees One Hundred and Twenty-Five Crore Only) divided into 12,50,00,000 (Twelve Crore Fifty Lakh) Equity Shares of Rs. 10/- each. Thereby alteration of the Authorised Share Capital - Clause 5 of the Memorandum of Association of the Company subject to necessary approvals of Members in their meeting. The details regarding item No. 3 as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January 2026 are as follows: Sl. Particulars Details 1 Name Pratibha Sharma (M. No. A38211) 2 Reason for change viz. appointment, Appointment as Company Secretary and resignation, removal, death or Compliance Officer of the Company. otherwise 3 Date of appointment/Cessation (as w.e.f. 03rd October, 2026 applicable) & term of appointment 4 Brief profile (in case of Mrs. Pratibha Sharma is an associate appointment) member of ICSI has experience in diverse fields in Company Law, Corporate Governance, Legal Compliance, Quality Control etc. She is having good exposure in Companies Act, 2013, Securities Exchange Board of India (SEBI) Regulations, Rules and circulars, Foreign Exchange Management Act (FEMA) etc. 5 Disclosure of relationships between -- Directors (in case of appointment of a director)